These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32417392)

  • 141. NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma.
    Feng L; Xu X; Zhao K
    Leuk Res; 2021 Dec; 111():106708. PubMed ID: 34536775
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
    Sarosiek KA; Malumbres R; Nechushtan H; Gentles AJ; Avisar E; Lossos IS
    Blood; 2010 Jan; 115(3):570-80. PubMed ID: 19965678
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas.
    Zeng WJ; Cheng Q; Wen ZP; Wang JY; Chen YH; Zhao J; Gong ZC; Chen XP
    J Cell Mol Med; 2020 Sep; 24(17):9613-9626. PubMed ID: 32667745
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.
    Li C; Thompson MA; Tamayo AT; Zuo Z; Lee J; Vega F; Ford RJ; Pham LV
    Oncotarget; 2012 Mar; 3(3):314-26. PubMed ID: 22447839
    [TBL] [Abstract][Full Text] [Related]  

  • 145. HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells.
    Yang D; Ma Y; Zhao P; Ma J; He C
    Exp Cell Res; 2021 Nov; 408(2):112860. PubMed ID: 34624323
    [TBL] [Abstract][Full Text] [Related]  

  • 146. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
    Zhou HE; Pan SS; Han H
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
    Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
    Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
    [TBL] [Abstract][Full Text] [Related]  

  • 148. β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma.
    Cai N; Chen Z; Huang Y; Shao S; Yu H; Wang Y; He S
    Cancer Biol Ther; 2020; 21(3):241-247. PubMed ID: 31731887
    [TBL] [Abstract][Full Text] [Related]  

  • 149. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.
    Zhang N; Wei P; Gong A; Chiu WT; Lee HT; Colman H; Huang H; Xue J; Liu M; Wang Y; Sawaya R; Xie K; Yung WK; Medema RH; He X; Huang S
    Cancer Cell; 2011 Oct; 20(4):427-42. PubMed ID: 22014570
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Hypothesis of Opposite Interplay Between the Canonical WNT/beta-catenin Pathway and PPAR Gamma in Primary Central Nervous System Lymphomas.
    Vallée A; Lecarpentier Y; Vallée JN
    Curr Issues Mol Biol; 2019; 31():1-20. PubMed ID: 30647194
    [TBL] [Abstract][Full Text] [Related]  

  • 151. [Long non-coding RNA regulates bone metabolism via Wnt/β-catenin signaling pathway].
    Yuan Y; Zhang L
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2342-2350. PubMed ID: 34327900
    [TBL] [Abstract][Full Text] [Related]  

  • 152. m
    Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
    Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
    Song T; He N; Hao Z; Yang Y
    J Cell Physiol; 2023 Jun; 238(6):1308-1323. PubMed ID: 36960713
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review.
    Khanmohammadi S; Fallahtafti P
    J Cell Mol Med; 2023 Jul; 27(14):1928-1946. PubMed ID: 37246627
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway.
    Cui Y; Wen Y; Lv C; Zhao D; Yang Y; Qiu H; Wang C
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894142
    [TBL] [Abstract][Full Text] [Related]  

  • 156. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
    Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
    J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties.
    Yang H; Wang L; Zheng Y; Hu G; Ma H; Shen L
    Bioengineered; 2022 Jan; 13(1):1686-1701. PubMed ID: 35001816
    [TBL] [Abstract][Full Text] [Related]  

  • 158. lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p.
    Tian Y; Li L; Lin G; Wang Y; Wang L; Zhao Q; Hu Y; Yong H; Wan Y; Zhang Y
    Leuk Lymphoma; 2021 Jul; 62(7):1574-1584. PubMed ID: 33682607
    [TBL] [Abstract][Full Text] [Related]  

  • 159. EGR1 Addiction in Diffuse Large B-cell Lymphoma.
    Kimpara S; Lu L; Hoang NM; Zhu F; Bates PD; Daenthanasanmak A; Zhang S; Yang DT; Kelm A; Liu Y; Li Y; Rosiejka A; Kondapelli A; Bebel S; Chen M; Waldmann TA; Capitini CM; Rui L
    Mol Cancer Res; 2021 Aug; 19(8):1258-1269. PubMed ID: 33980611
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Peptide mimetic NC114 induces growth arrest by preventing PKCδ activation and FOXM1 nuclear translocation in colorectal cancer cells.
    Taguchi Y; Nakaya T; Aizawa K; Noguchi Y; Maiya N; Iwamoto C; Ohba K; Sugawara M; Murata M; Nagai R; Kano F
    FEBS Open Bio; 2024 Apr; 14(4):695-720. PubMed ID: 38425293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.